Psychiatry - July 2008 - (Page 66)

Journal Watch performance-enhancing drugs and supplements by women and girls in sports. PMID: 18001612 Performance-enhancing drug use in young athletes. Laos C, Metzl JD. Adolesc Med Clin. 2006 Oct;17(3):719–731; abstract xii. Review. Synopsis: Authors review substances used by adolescent athletes, describe their effects, consider why they are increasing in use, and discuss how to educate adolescents on alternate means of enhancing athletic performance. PMID: 17030288 Substance use in athletics: a sports psychiatry perspective. McDuff DR, Baron D. Clin Sports Med. 2005 Oct;24(4):885–897, ix–x. Review. Synopsis: In this paper, authors review prevalence and patterns of use, health and performance effects, and preventive and treatment interventions for alcohol, tobacco, stimulants, and steroids in athletes. Authors also consider each substance in light of abuse/addiction and performance enhancement models, discuss similarities/differences between college and professional athletes, and make suggestions for future research. PMID: 16169452 Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. Pagonis TA, Angelopoulos NV, Koukoulis GN, Hadjichristodoulou CS. Eur Psychiatry. 2006 Dec;21(8):551–562. Epub 2005 Dec 13. Synopsis: To evaluate the psychological consequences of the 66 a quick look at the noteworthy articles in psychiatry research JULY 2008 by Laura G. Alexander ATHLETES AND PERFORMANCEENHANCING DRUGS Enhancement drugs and the athlete. Botrè F, Pavan A. Neurol Clin. 2008 Feb;26(1):149–167; ix. Review. Synopsis: Authors review the evolution of performanceenhancing substances in sports, methods of use, potential risks of abuse, the organization responsible for anti-doping tests, problems of drug associations, and problems with designer steroids and nutritional supplements. PMID: 18295088 Hormone abuse in sports: the antidoping perspective. Barroso O, Mazzoni I, Rabin O. Asian J Androl. 2008 66 Psychiatry 2008 [ J U L Y ] May;10(3):391–402. Synopsis: Authors review the use of hormones as performanceenhancing drugs in sports, with a focus on peptide hormones (erythropoietin, human growth hormone, insulin, and insulin-like growth factor I), which appear to be widely abused and difficult to detect. Authors also discuss hormones and hormone modulators being developed by the pharmaceutical industry that have the potential to be abused. PMID: 18385901 Performance-enhancing drugs and supplements in women and girls. Matich AJ. Curr Sports Med Rep. 2007 Dec;6(6):387–391. Review. Synopsis: In this article, the author discusses the abuse of

Table of Contents Feed for the Digital Edition of Psychiatry - July 2008

Psychiatry - July 2008 Editor's Message Editorial Advisory Board Contents PsychRx Letters to the Editor Reliability of Diagnoses: Do Psychiatrists Use Structured Interviews In Real Clinical Settings? Trend Watch: Use of Atypical Antipsychotics in the Elderly Review: The Struggle for Mental Healthcare in New Orleans-One Case at a Time Psychotherapy Rounds: Psychotherapeutic and Adjuntive Pharmacologic Approaches to Treating Posttraumatic Stress Disorder Original Research: Baseline Dissociation and Prospective Success in Special Forces Assessment and Selection Commentary: Performance-Enhancing Drugs: Where Should the Line Be Drawn and By Whom? Commentary: Psychiatric Diagnosis and the Pathlogist's View of Schizophrenia Journal Watch Classified Advertising Information for Authors

Psychiatry - July 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.